Access comprehensive financial analyses and make smarter investments - get the Manual of Investments on Amazon!

ARM

Considering Investing in Series? Here's What You Need to Know

Shares of Series have moved -0.6% today, and are now trading at a price of $137.16. In contrast, the S&P 500 index saw a -0.0% change. Today's trading volume is 518,435 compared to the stock's average volume of 4,861,977.

Arm Holdings plc architects, develops, and licenses central processing unit products and related technologies for semiconductor companies and original equipment manufacturers. Based in Cambridge, United Kingdom the company has 8,330 full time employees and a market cap of $145,282,809,856.

The company is now trading -9.85% away from its average analyst target price of $152.14 per share. The 33 analysts following the stock have set target prices ranging from $80.0 to $210.0, and on average give Series a rating of buy.

Over the last 52 weeks, ARM stock has risen 7.0%, which amounts to a -8.1% difference compared to the S&P 500. The stock's 52 week high is $182.88 whereas its 52 week low is $80.0 per share. With its net margins declining an average -5.7% over the last 4 years, Series may not have a strong enough profitability trend to support its stock price.

Date Reported Total Revenue ($ k) Net Profit ($ k) Net Margins (%) YoY Growth (%)
2024 4,007,000 792,000 20 -23.08
2023 983,000 252,000 26 136.36
2022 824,000 87,000 11 -56.0
2021 724,000 182,000 25
The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.

IN FOCUS